Recombinant multi-species FIGF/VEGFD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FIGF/VEGFD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus. [provided by RefSeq, Feb 2011]
The Alternative Names of target: FIGF,Figf,VEGF-D,VEGFD,Vascular endothelial growth factor D,Vegf-d,Vegfd,c-Fos-induced growth factor (FIGF)

Target products collectionGo to FIGF/VEGFD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T63803-Ag-1/ GM-Tg-hg-T63803-Ag-2 Human FIGF/VEGFD protein Human
GM-Tg-rg-T63803-Ag-1/ GM-Tg-rg-T63803-Ag-2 Rat FIGF/VEGFD protein Rat
GM-Tg-mg-T63803-Ag-1/ GM-Tg-mg-T63803-Ag-2 Mouse FIGF/VEGFD protein Mouse
GM-Tg-cynog-T63803-Ag-1/ GM-Tg-cynog-T63803-Ag-2 Cynomolgus/Rhesus macaque FIGF/VEGFD protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T63803-Ag-1/ GM-Tg-felg-T63803-Ag-2 Feline FIGF/VEGFD protein Feline
GM-Tg-cang-T63803-Ag-1/ GM-Tg-cang-T63803-Ag-2 Canine FIGF/VEGFD protein Canine
GM-Tg-bovg-T63803-Ag-1/ GM-Tg-bovg-T63803-Ag-2 Bovine FIGF/VEGFD protein Bovine
GM-Tg-equg-T63803-Ag-1/ GM-Tg-equg-T63803-Ag-2 Equine FIGF/VEGFD protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T63803-Ag-1/ GM-Tg-hg-T63803-Ag-2; GM-Tg-rg-T63803-Ag-1/ GM-Tg-rg-T63803-Ag-2;
GM-Tg-mg-T63803-Ag-1/ GM-Tg-mg-T63803-Ag-2; GM-Tg-cynog-T63803-Ag-1/ GM-Tg-cynog-T63803-Ag-2;
GM-Tg-felg-T63803-Ag-1/ GM-Tg-felg-T63803-Ag-2; GM-Tg-cang-T63803-Ag-1/ GM-Tg-cang-T63803-Ag-2;
GM-Tg-bovg-T63803-Ag-1/ GM-Tg-bovg-T63803-Ag-2; GM-Tg-equg-T63803-Ag-1/ GM-Tg-equg-T63803-Ag-2
Products Name FIGF/VEGFD protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FIGF/VEGFD
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FIGF/VEGFD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.